EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mattia Glauber
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerillo, A. G.
Right arrow Articles by Glauber, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerillo, A. G.
Right arrow Articles by Glauber, M.
Related Collections
Right arrow Cardiac - physiology
Right arrow Coronary disease
Right arrow Electrophysiology - arrhythmias

Eur J Cardiothorac Surg 2003;24:487-492
© 2003 Elsevier Science NL


Free triiodothyronine: a novel predictor of postoperative atrial fibrillation

Alfredo Giuseppe Cerillo*, Stefano Bevilacqua, Simona Storti, Massimiliano Mariani, Enkel Kallushi, Andrea Ripoli, Aldo Clerico, Mattia Glauber

U.O. Cardiochirurgia Adulti, Institute of Clinical Physiology, The National Research Council, ‘CREAS’, Massa, Italy

Received 19 March 2003; received in revised form 30 May 2003; accepted 15 June 2003.

* Corresponding author. Tel.: +39-0585-493-604; fax: +39-0585-493-614
e-mail: cerillo{at}ifc.cnr.it

Objective: Despite improved perioperative management, atrial fibrillation (AF) after coronary artery bypass grafting (CABG) remains a relevant clinical problem, whose pathogenetic mechanisms remain incompletely explained. A reduced incidence of postoperative AF has been described in CABG patients receiving IV tri-iodothyronine (T3). This study was designed to define the role of thyroid metabolism on the genesis of postoperative AF. Methods and results: Free T3 (fT3), free thyroxine (fT4), and thyroid stimulating hormone were assayed at admission in 107 consecutive patients undergoing isolated CABG surgery. Patients with thyroid disease or taking drugs known to interfere with thyroid function were excluded. A preoperative rhythm other than sinus rhythm was considered an exclusion criterion. Thirty-three patients (30.8%) had postoperative AF. An older age (P=0.03), no therapy with ß-blockers (P=0.08), chronic obstructive pulmonary disease (P=0.08), lower left ventricle ejection fraction (P=0.09) and lower fT3 concentration (P=0.001), were univariate predictors of postoperative AF. On multivariate analysis, low fT3 concentration and lack of ß-blocking therapy were independently related with the development of postoperative AF (odds ratio, OR, 4.425; 95% confidence interval, CI, 1.745–11.235; P=0.001 and OR 3.107; 95% CI 1.087–8.875; P=0.03, respectively). Postoperative AF significantly prolonged postoperative hospital stay (P=0.002). Conclusions: Low basal fT3 concentration can reliably predict the occurrence of postoperative AF in CABG patients.

Key Words: Atrial fibrillation • Thyroid hormone • Coronary artery bypass grafting







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.